Percutaneous Coronary Intervention: Clinical Updates and Perspectives

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiovascular Medicine".

Deadline for manuscript submissions: 22 December 2024 | Viewed by 777

Special Issue Editor


E-Mail
Guest Editor
1. Cardiology Department, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 124 62 Athens, Greece
2. Department of Cardiology, Mitera General Hospital, 151 23 Athens, Greece
Interests: coronary artery disease; atherosclerosis; coronary intervention; myocardial infarction; sudden cardiac death; takotsubo cardiomyopathy

Special Issue Information

Dear Colleagues,

It has been more than 40 years since the first percutaneous coronary angioplasty (PCI) was performed. Since then, significant advances in the field of interventional cardiology have been accomplished. In contemporary clinical practice, radial artery is considered the safest site for access, substituting the femoral artery as the by-default option for gaining access. Intracoronary imaging (intravascular ultrasound and optical coherence tomography)-guided PCI has been associated with better outcomes compared to conventional PCI. Whether the functional assessment of lesions is beneficial for the patient or not is contested, with both positive and negative studies published recently. New cutting-edge devices have been added to the armamentarium of the interventional cardiologist, facilitating PCI and improving its results. Intravascular lithotripsy is a safe and effective option for the preparation of severely calcified lesions. New-generation stent platforms have reduced the rates of in-stent restenosis, and they have overcome first-generation drug-eluting stents’ Achilles hill, namely stent thrombosis, while drug-eluting balloons aspire to overcome stent-related complications by leaving no material in the patient's coronary artery tree. Although complete revascularization in the setting of myocardial infarction should be the ultimate goal of every interventional cardiologist, the impact of PCI on hard endpoints concerning stable coronary artery disease is under dispute.

Dr. Iosif Xenogiannis
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • percutaneous coronary intervention (PCI)
  • intravascular ultrasound (IVUS)
  • optical coherence tomography (OCT)
  • radial access
  • drug-eluting balloons (DEB)
  • drug-eluting stents (DES)

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

11 pages, 1706 KiB  
Article
Impact of Drug-Coated Balloon-Based Revascularization in Patients with Chronic Total Occlusions
by Eun-Seok Shin, Ae-Young Her, Mi Hee Jang, Bitna Kim, Sunwon Kim and Houng Bang Liew
J. Clin. Med. 2024, 13(12), 3381; https://doi.org/10.3390/jcm13123381 - 9 Jun 2024
Viewed by 564
Abstract
Background: Percutaneous coronary intervention (PCI) with a drug-eluting stent (DES) for chronic total coronary occlusions (CTOs) improves clinical symptoms and quality of life. However, data on drug-coated balloon (DCB)-based PCI in CTO lesions are limited. Methods: A total of 200 patients were successfully [...] Read more.
Background: Percutaneous coronary intervention (PCI) with a drug-eluting stent (DES) for chronic total coronary occlusions (CTOs) improves clinical symptoms and quality of life. However, data on drug-coated balloon (DCB)-based PCI in CTO lesions are limited. Methods: A total of 200 patients were successfully treated for CTO lesions, either with DCB alone or in combination with DES (DCB-based PCI). They were compared with 661 patients who underwent second-generation DES implantation for CTO from the PTRG-DES registry (DES-only PCI). The endpoint was major adverse cardiovascular events (MACEs), which included a composite of cardiac death, myocardial infarction, stent or target lesion thrombosis, target vessel revascularization, and major bleeding at 2 years. Results: In the DCB-based PCI group, 49.0% of patients were treated with DCB only and 51.0% underwent the hybrid approach combining DCB with DES. Bailout stenting was performed in seven patients (3.5%). The DCB-based PCI group exhibited fewer stents (1.0; IQR: 0.0–1.0 and 2.0; IQR: 1.0–3.0, p < 0.001), shorter stent lengths (6.5 mm; IQR: 0.0–38.0 mm and 42.0 mm; IQR: 28.0–67.0 mm, p < 0.001), and lower usage of small stents with a diameter of 2.5 mm or less (9.8% and 36.5%, p < 0.001). Moreover, the DCB-based PCI group had a lower rate of MACEs than the DES-only PCI group (3.1% and 13.2%, p = 0.001) at 2-year follow-up. Conclusions: The DCB-based PCI approach significantly reduced the stent burden, particularly in the usage of small stent diameters, and resulted in a lower risk of MACEs compared to DES-only PCI in CTO lesions. Full article
(This article belongs to the Special Issue Percutaneous Coronary Intervention: Clinical Updates and Perspectives)
Show Figures

Figure 1

Back to TopTop